ATC Group: D11AX01 Minoxidil

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of D11AX01 in the ATC hierarchy

Level Code Title
1 D Dermatologicals
2 D11 Other dermatological preparations
3 D11A Other dermatological preparations
4 D11AX Other dermatologicals
5 D11AX01 Minoxidil

Active ingredients in D11AX01

Active Ingredient Description
Minoxidil

Topical administration of minoxidil stimulates hair growth in men and women with androgenic alopecia. The mechanism of stimulating hair growth from minoxidil is not fully understood, but some actions of minoxidil include increasing hair diameter, stimulating new growth and prolonging the developmental phase, and stimulating hair follicle transition from resting phase (telogen) in the growth phase (regenerative).

Related product monographs

Title Information Source Document Type  
MINORGA Cutaneous solution Medicines Authority (MT) MPI, EU: SmPC
REGAINE FOAM Cutaneous foam Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicines in this ATC group

Austria (AT)

Cyprus (CY)

Estonia (EE)

Finland (FI)

France (FR)

Hong Kong (HK)

Ireland (IE)

Lithuania (LT)

Malta (MT)

New Zealand (NZ)

Romania (RO)

Singapore (SG)

South Africa (ZA)

Tunisia (TN)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.